Viewing Study NCT06422520

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:16 AM
Ignite Modification Date: 2026-02-03 @ 3:47 AM
Study NCT ID: NCT06422520
Status: RECRUITING
Last Update Posted: 2025-11-20
First Post: 2024-05-15
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A First-in-Human Study of BGB-C354 Alone and in Combination With Tislelizumab in Participants With Advanced Solid Tumors
Sponsor: BeiGene
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Solid Tumor View
Keywords:

Keywords

Keyword Brief Keyword Text View
None BGB-C354 View
None Tislelizumab View
None First-in-human View
None Advanced solid tumor View
None Anti-PD-1 Monoclonal Antibody View
None B7H3 View
None antibody drug conjugate View